A case report: Hypertrophic pachymeningitis and IgG4‐related disease
- 11 November 2024
- journal article
- letter
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 27 (11) , e15410
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Perspectives on current and emerging therapies for immunoglobulin G4–related diseaseModern Rheumatology, 2022
- Refractory IgG4-related disease complicated with organising pneumonia and hypertrophic pachymeningitisModern Rheumatology Case Reports, 2022
- The neurology of IGG4-related diseaseJournal of the Neurological Sciences, 2021
- Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature reviewSeminars in Arthritis and Rheumatism, 2019
- Clinical features of hypertrophic pachymeningitis in a center surveyNeurological Sciences, 2018
- Infliximab for IgG4-Related Orbital DiseaseOphthalmic Plastic & Reconstructive Surgery, 2017
- Neurological Manifestations of IgG4-Related DiseaseCurrent Treatment Options in Neurology, 2017
- Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximabJournal of Clinical Neuroscience, 2015
- IgG4-related disease of the infratemporal fossa: A case reportJournal of Oral and Maxillofacial Surgery, Medicine, and Pathology, 2012
- IgG4-Related DiseaseNew England Journal of Medicine, 2012